revenue from bad debt recovery continued growing by 19% y-y and the revenue from overseas subsidiaries grew by 18% y-y. Details of each business can be described as follows: Profit and Loss Statement
e for and be r 26 , 2019. required an eholders No. etermined to m B ,Interlink . The details Shareholders ompany and e Company apital ompany and e Company pital y shares of he meeting or the newly he
) Issuing and offering convertible debenture than could be convert to the Company’s ordinary shares (“Convertible Debenture”) of a total value of THB 265,000,000 to SUTGH (Details of Convertible Debenture are
Debenture”) of a total value of THB 265,000,000 to SUTGH (Details of Convertible Debenture are prescribed in the Summary of Key Terms and Conditions of the Offering and Allocation of the Newly Issued
) who is approved by SEC and express an opinion on the transaction. For details, please see Information Memorandum on the Acquisition of Assets and the Connected Transaction of the Company (Enclosure 1
medical equipment as well as medical service concerning health and esthetics. 2. Overview of operating results in the Year 2017. The overall global economy still has growth direction in fine criteria from
continuously. As well, the Company also aims to expand business to CLMV countries (Cambodia, Lao PDR, Myanmar, and Vietnam); which are the countries having interesting growth direction of business. The Company
), total revenue from sales amounted to THB 3,862 million, an increase of THB 235 million or 6.5%, driven by higher sales of the energy drinks for export markets and revenue growth in distribution of 3rd
to monitor the situation closely in order to conduct the appropriate measures. For more details, please see section “COVID-19: Impacts and Response Plan” 1Q 2020 PERFORMANCE 1Q 2020 P&L SNAPSHOT AND